AZTA
Azenta, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$33.24
−1.16%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$33.44
From 52W high−18.95%
Volume1.36M
Market cap$1.46B
P/E (TTM)—
P/S (TTM)2.4x
Div yield—
Key dataSep 18, 2026
Open
$33.44
From 52W high
−18.95%
Volume
1.36M
Market cap
$1.46B
ValuationView details →
P/E (Fwd)
59.6x
EV/EBITDA
−12.3x
P/E (TTM)
—
RSI (14)
58.9
MomentumView details →
1D Return
−1.16%
YTD Return
+0.68%
SummaryUpdated Jun 1, 2026
Azenta, Inc. (NASDAQ:AZTA) is a life sciences company that provides sample exploration and management solutions to pharmaceutical companies, biotechnology firms, biorepositories, and research institutes globally. Founded in 1978 as Brooks Automation, the company underwent a significant transformation in 2021 when it changed its name to Azenta and refocused entirely on the life sciences sector after divesting its semiconductor automation business. Headquartered in Chelmsford, Massachusetts, Azenta operates through two primary segments: Life Sciences Products and Life Sciences Services, serving customers across North America, Europe, China, and the Asia Pacific region.
Similar companies
Latest newsMore news →
Azenta, Inc. granted Senior Vice President, General Counsel and Corporate Secretary Ephraim Starr a retention award of restricted stock units valued at $500,000 effective September 14, 2026.3d agoAzenta, Inc. granted Executive Vice President and Chief Financial Officer Lawrence Lin a retention award of restricted stock units valued at $1,000,000 effective September 14, 2026.3d agoAzenta, Inc. appointed Robyn C. Davis to its Nominating and Governance Committee effective September 14, 2026.3d ago